Project Overview: The AIR Project investigates the uptake of COVID-19 and influenza vaccines among individuals with severe mental illness (SMI) in Australia. This research is crucial as people with SMI, such as schizophrenia, are particularly vulnerable to severe outcomes from COVID-19 and influenza due to factors like physical comorbidities and reduced access to healthcare.
Research Aims:
Key Objectives:
Expected Outcomes: The findings will inform policies to ensure equitable vaccine delivery, aiming to increase vaccine uptake among people with SMI. This could lead to reduced hospital admissions and mortality rates, ultimately easing the burden on healthcare systems and improving health outcomes for this vulnerable population.
Project Team: The project is led by a multidisciplinary team of experts from The University of Queensland, Griffith University, Curtin University, and the University of Melbourne, with funding from the NHMRC Investigator Grant and the ALIVE National Centre.
Significance: By addressing the vaccination disparities in people with SMI, the AIR Project aims to promote health equity and enhance the overall wellbeing of individuals with severe mental illness.
ALIVE Next Generation Researcher Network Application Form Click here
For University based research higher degree students, early/mid-career mental health researchers
ALIVE Lived Experience Research Collective Application Form Click here
For University and community based lived-experience or carer-focused mental health researchers at all career stages
ALIVE Collective Application Form Click here
For any individuals or organisations with a general interest in supporting the special initiative in mental health
ALIVE Implementation and Translation Network (ITN) Application Form Click here
For sector, service delivery organisations in mental health serving people across the life course and priority populations
If you have a general enquiry about The Alive National Centre for Mental Health Research Translation, please submit an enquiry below